Mr Abraham Chan donates HK$250,000 to support second International Summit on Innovative Drug Discovery

17 June 2014


The University recently received a generous donation of HK$250,000 from Mr Abraham Chan, HKBU Honorary University Fellow and Chairman of PuraPharm Group of Companies, to support the 2014 International Summit on Innovative Drug Discovery – Charting the Course of Standardisation of Chinese Materia Medica to be held by the School of Chinese Medicine (SCM) in November.  

In recognition of Mr Chan’s generosity, a cheque presentation ceremony was held today (17 June). On behalf of the University, Professor Albert Chan, President and Vice-Chancellor, received the donation from Mr Chan. Guests present included Professor Bian Zhaoxiang, Associate Vice-President and Director of the Clinical Division of SCM, Professor Lu Aiping, Dean of Chinese Medicine, and SCM staff. 

SCM is committed to pursuing innovative research for the development of Chinese medicine, the promotion of human health and the prevention of diseases. To fulfill this mission, the School has identified innovative drug discovery as one of its strategic focuses and since 2012 has held a biennial International Summit on Innovative Drug Discovery. By hosting the Summit with different focuses on new drug discovery in Chinese medicine, SCM aims at providing a regular and sustainable platform for exchange and sharing of latest research findings in the field so as to advance the drug discovery process. The second Summit will focus on the standardisation of Chinese medicines which would serve as an important basis for new drug discovery.

Professor Albert Chan (fourth from right) receives the donation from Mr Abraham Chan (fourth from left) on behalf of HKBU